
Lindsay France/Cornell Brand Communications
Chris Schaffer, left, and Nozomi Nishimura, associate professors in the Meinig School of Biomedical Engineering.
You know that dizzy feeling you get when, after lying down for an extended period, you stand up a little too quickly?
That feeling is caused by a sudden reduction of blood flow to the brain, a reduction of around 30 percent. Now imagine living every minute of every day with that level of decreased blood flow.
People with Alzheimer’s disease don’t have to imagine it. The existence of cerebral blood flow reduction in Alzheimer’s patients has been known for decades, but the exact correlation to impaired cognitive function is less understood.
“People probably adapt to the decreased blood flow, so that they don’t feel dizzy all of the time, but there’s clear evidence that it impacts cognitive function,” said Chris Schaffer, associate professor in the Meinig School of Biomedical Engineering.
The Latest on: Alzheimer’s
via Google News
The Latest on: Alzheimer’s
- Rotten egg gas may help protect aging brain cells from Alzheimer’s diseaseon January 12, 2021 at 4:00 pm
Typically characterized as poisonous, corrosive and smelling of rotten eggs, hydrogen sulfide's reputation may soon get a face-lift thanks to Johns Hopkins Medicine researchers.
- Lilly’s anti-amyloid antibody donanemab renews Alzheimer’s hopeson January 12, 2021 at 3:55 pm
Eli Lilly’s amyloid-targeting antibody donanemab has shown promise in the treatment of Alzheimer’s disease, sending its stocks soaring and renewing hope for the notoriously complex research area. In ...
- Alzheimer's Progression Tracks With Blood Biomarkerson January 12, 2021 at 3:11 pm
Blood-based biomarkers paralleled the progression of Alzheimer's disease neurodegeneration, a large longitudinal cohort study showed. Increases of phosphorylated tau at threonine 181 (p-tau181) in ...
- Eli Lilly Has Good News About Its Alzheimer’s Drug. Here’s What It Means for Biogen.on January 12, 2021 at 12:52 pm
Eli Lilly’s optimistic results for its Alzheimer’s drug in a clinical trial is a good sign for rival Biogen, which is looking for its similar drug to be approved.
- Rotten egg gas could guard against Alzheimer's diseaseon January 12, 2021 at 11:42 am
Typically characterized as poisonous, corrosive and smelling of rotten eggs, hydrogen sulfide's reputation may soon get a face-lift thanks to researchers. In experiments in mice, researchers have ...
- New drug and blood test developed for Alzheimer'son January 12, 2021 at 11:25 am
The new drug may slow the rate of cognitive decline, and the new blood test is easier to administer. Neither have FDA approval yet.
- Hydrogen sulfide could guard against Alzheimer's diseaseon January 12, 2021 at 5:18 am
Typically characterized as poisonous, corrosive and smelling of rotten eggs, hydrogen sulfide's reputation may soon get a facelift. In experiments in mice, researchers have shown the foul-smelling gas ...
- Study Identifies Vulnerable Neurons in Alzheimer’s Diseaseon January 12, 2021 at 5:00 am
Scientists characterize selectively vulnerable neuronal populations using single-nucleus RNA sequencing in postmortem brains spanning the progression of Alzheimer’s tau neurofibrillary pathology and ...
- Evidence Suggests There Are Three Subtypes Of Alzheimer'son January 12, 2021 at 3:40 am
Alzheimer’s disease is often seen as a single monolithic disease, but an increasing amount of evidence is showing that this might not necessarily be the ca ...
- Full interview with Eli Lilly CEO David Ricks on Alzheimer's data, Covid treatmenton January 12, 2021 at 2:56 am
Eli Lilly CEO David Ricks joined CNBC's Meg Tirrell on "Squawk Box" to discuss the company's latest positive data on its Alzheimer's treatment as well as the latest on the company's Covid antibody ...
via Bing News